Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
57.22
+1.89 (3.42%)
At close: Dec 15, 2025
Chugai Pharmaceutical Market Cap
Chugai Pharmaceutical has a market cap or net worth of $87.9 billion as of December 16, 2025. Its market cap has increased by 29.98% in one year.
Market Cap
87.90B
Enterprise Value
82.20B
Revenue
8.20B
Ranking
n/a
PE Ratio
32.75
Stock Price
$57.22
Market Cap Chart
Since January 6, 1992, Chugai Pharmaceutical's market cap has increased from 2.50B to 87.90B, an increase of 3,414.86%. That is a compound annual growth rate of 11.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 87.64B | 19.61% |
| Dec 30, 2024 | 73.28B | 17.53% |
| Dec 29, 2023 | 62.35B | 48.41% |
| Dec 30, 2022 | 42.01B | -21.23% |
| Dec 30, 2021 | 53.34B | -39.09% |
| Dec 30, 2020 | 87.57B | 72.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |